Old Web
English
Sign In
Acemap
>
authorDetail
>
Shinichi Nishiuma
Shinichi Nishiuma
Eli Lilly and Company
Postmarketing surveillance
Medicine
Pemetrexed
Pathology
Survival rate
5
Papers
20
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
[Safety and effectiveness of pemetrexed in patients with non-small cell lung cancer in Japan - analysis of post-marketing surveillance].
2014
Gan to kagaku ryoho. Cancer & chemotherapy
Sumiko Okubo
Noriko Kobayashi
Masanori Taketsuna
Kaneko N
Enatsu S
Shinichi Nishiuma
Show All
Source
Cite
Save
Citations (3)
Safety and Effectiveness of Gemcitabine in 260 Patients with Biliary Tract Cancer in a Japanese Clinical Practice Based on Post-marketing Surveillance in Japan
2012
Japanese Journal of Clinical Oncology
Sumiko Okubo
Shinichi Nishiuma
Noriko Kobayashi
Masanori Taketsuna
Hisashi Taniai
Show All
Source
Cite
Save
Citations (1)
Safety and effectiveness of pemetrexed in patients with malignant pleural mesothelioma based on all-case drug-registry study
2012
Lung Cancer
Kozo Kuribayashi
Simon Voss
Shinichi Nishiuma
Kimiko Arakawa
Yoshitaka Nogi
Koji Mikami
Shoji Kudoh
Show All
Source
Cite
Save
Citations (7)
Solanezumab was safe and well-tolerated for Asian patients with mild-to-moderate Alzheimer's disease in a multicenter, randomized, open-label, multi-dose study
2010
Alzheimers & Dementia
Taro Goto
Shinji Fujikoshi
Kazunori Uenaka
Shinichi Nishiuma
Eric Siemers
Robert A. Dean
Michihiro Takahashi
Show All
Source
Cite
Save
Citations (7)
P4-379: Safety, tolerability, pharmacokinetics and pharmacodynamics of multiple-dose administration of a gamma-secretase inhibitor in Japanese subjects
2008
Alzheimers & Dementia
Miki Kumamoto
Masako Nakano
Kazunori Uenaka
Stephen L. Lowe
Shinichi Nishiuma
Noboru Nakamichi
Robert A. Dean
Eric Siemers
Richard C. Mohs
Show All
Source
Cite
Save
Citations (2)
1